Angeas Health Care Limited
Wholesale trading of pharmaceutical and medical goods, including manufacturing, importing, exporting, and selling.
2003 | Mumbai, Maharashtra (India) | Active
Angeas Health Care Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.52 M
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 3.30 Cr
- Revenue Growth -92.03%
- Profit Growth 95.92%
- Ebitda 78.46%
- Net Worth -0.20%
- Total Assets -38.58%
About Angeas Health Care
Angeas Health Care Limited (AHCL) is a Public Limited Indian Non-Government Company incorporated in India on 17 July 2003 and has a history of 21 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.52 M.
The company currently has active open charges totaling ₹3.30 Cr.
Satish Surana, Yashwant Surana, and Sushil Surana serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85113MH2003PLC141378
- Company No.
141378
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2003
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Who are the key members and board of directors at Angeas Health Care?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Surana  | Whole-Time Director | 17-Jul-2003 | Current |
| Yashwant Surana | Whole-Time Director | 17-Jul-2003 | Current |
| Sushil Surana | Director | 05-Mar-2010 | Current |
Financial Performance of Angeas Health Care.
Angeas Health Care Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 92.03% decrease. The company also saw a substantial improvement in profitability, with a 95.92% increase in profit. The company's net worth dipped by a decrease of 0.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Angeas Health Care?
In 2015, Angeas Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Raja Antibiotics Limited
Satish Surana and Sushil Surana are mutual person
Charges (Loans)
Open Charges
₹33.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- The Shamrao Vithal Co-Op. Bank Ltd. : 2.00 Cr
- Dena Bank : 1.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Apr 2008 | The Shamrao Vithal Co-Op. Bank Ltd. | ₹2.00 Cr | Open |
| 15 Mar 2007 | Dena Bank | ₹1.30 Cr | Open |
How Many Employees Work at Angeas Health Care?
Unlock and access historical data on people associated with Angeas Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Angeas Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Angeas Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
